Number of shares and voting rights as at 28/02/2018
Europlasma declares the number of voting rights and shares comprising its share capital as at 28th February.
Convertible bonds financing contract for a maximum amount of EUR 8 million
Europlasma signed today a contract for the issuance of convertible bonds into shares with the Luxembourg European High Growth Opportunities Securitization Fund.
Number of shares and voting rights as at 31/01/2018
Europlasma declares the number of voting rights and shares comprising its share capital as at 31st January.
Half-year report on liquidity contract as at 31/12/2017
Under the liquidity contract agreed between the company and Kepler Cheuvreux, as at 31 December 2017.
Number of shares and voting rights as at 30/12/2017
Europlasma declares the number of voting rights and shares comprising its share capital as at 31st December.
The European Investment Bank intends to support the CHO Tiper project by providing up to 30 million euro of debt financing
Pictures of the ceremony held in Brussels at the European Commission on 20 December 2017
Number of shares and voting rights as at 30/11/2017
Europlasma declares the number of voting rights and shares comprising its share capital as at 30th November.
Information relative to BSAR C
After closing of the trading day on October 31, 2017, Europlasma granted 152,405,521 warrants (BSAR C) for the benefit of the company’s shareholders on the basis of one BSAR C for one Europlasma ordinary share registered, giving the right to subscribe for a total of 38,101,380 new shares.
Number of shares and voting rights as at 31/10/2017
Europlasma declares the number of voting rights and shares comprising its share capital as at 31st October.
Free allocation of stock warrants
Following the approval by the shareholders of the 3rd resolution at the Shareholders' Meeting on 26/10/2017, the company issued redeemable share warrants (BSAR C).